Autonomix Medical (AMIX) Cash from Financing Activities (2023 - 2025)

Autonomix Medical (AMIX) has 3 years of Cash from Financing Activities data on file, last reported at $5.4 million in Q4 2025.

• On a quarterly basis, Cash from Financing Activities fell 39.46% year-over-year to $5.4 million in Q4 2025; TTM through Dec 2025 was $19.0 million, a 18.77% decrease from a year earlier, with the FY2024 full-year figure at $14.4 million, up 2034.81% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $5.4 million, up from $2.7 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for AMIX reached as high as $14.4 million in Q1 2024 and fell as low as $350000.0 in Q3 2023.
• Historically, Cash from Financing Activities has averaged $4.8 million across 3 years, with a median of $2.7 million in 2023.
• Across the five-year window, Cash from Financing Activities jumped 2034.81% in 2024 and tumbled 39.46% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at $1.6 million in 2023, then jumped by 445.53% to $9.0 million in 2024, then tumbled by 39.46% to $5.4 million in 2025.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $5.4 million in Q4 2025, $2.7 million in Q3 2025, and $2.1 million in Q2 2025.